Precise Ablation Technologies

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam et tempus magna. Aenean tempor pellentesque egestas. Vestibulum in neque sed nulla sollicitudin consectetur sed et lectus.

Transurethral Ultrasound
Ablation of the Prostate

TULSA-PRO® is CE marked, Health Canada approved, and 510(k)
cleared by the U.S. Food and Drug Administration (“FDA”).

Learn More

  • Precise

    Real-time MRI temperature monitoring enables gradual, gentle heating of prostate tissue to achieve cell death, degree by degree. TULSA-PRO uses this closed-loop feedback to ensure ablation accuracy by automatically adjusting the energy throughout the procedure.

  • Flexible

    The TULSA Procedure offers customizable treatment planning and 360-degree targeting capability, providing physicians with the flexibility to ablate prescribed tissue volumes in men with localized prostate cancer, prostate cancer combined with obstructive BPH, localized radio-recurrent prostate cancer, or large volume BPH.

  • Durable

    The TULSA procedure has demonstrated durable efficacy and safety, supported by 20+ clinical publications with up to 5-year outcomes.

  • Safe

    Patient safety is paramount in the TULSA Procedure. With MRI guidance, real-time monitoring, and precise control, the treatment is administered accurately, minimizing complications and prioritizing the well-being of the patient.

News & Publications

Learn More

TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting

May 01, 2023 16:30 ET | Source: Profound Medical Corp. Follow

Presentations reinforce the safety, efficacy and durability of the TULSA procedure, further supporting its potential as a mainstream, whole gland or focal treatment for prostate disease

Have Questions?

Contact Us